Patent · US Active

Ultrapure hypoallergenic solutions of sacrosidase

US9255261B2 · kind B2 · utility

3Cited by
5References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 2014
Grant dateFeb 9, 2016
Priority date
Expiry dateFeb 7, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

One aspect provides an ultrapure, hypoallergenic sacrosidase. Another aspect provides a solution of sacrosidase in about 1:1 glycerol/water having an enzymatic activity of at least about 7500 IU/mL and a residual papain concentration that does not include an allergic reaction in a human patient when given a dose of about 2.0 mL/day.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.